Skip to Main Content

News Center

Joga Gobburu

Gilead Sciences and University of Maryland School of Pharmacy Collaborate to Develop Future Leaders in Pharmacometrics

August 20, 2021

New two-year postdoctoral fellowship will provide hands-on technical training, unique drug development experiences, and supervised research projects.

University of Maryland, Baltimore (UMB) Grants Pumas-AI Exclusive License of Analytics Platform to Enhance Drug Development

August 16, 2021

Company spun out of University of Maryland School of Pharmacy provides a sophisticated pharmaceutical modeling and simulation platform with upgraded Productivity and Compliance Suites.

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

May 7, 2020

Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

Pumas-AI Launches Pumas Software to Advance Drug Development, Patient Care

July 19, 2019

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.

Gobburu Receives ASCPT’s Sheiner-Beal Pharmacometrics Award

March 15, 2019

International award recognizes outstanding achievements at the forefront of research or leadership in the field of pharmacometrics.

SOP, UCSF Partner for New Initiative on Pediatric Drug and Device Development

September 11, 2017

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.

CTM, FDA Collaborate to Assess Extrapolation of Anti-Epileptic Drugs’ Effectiveness

March 24, 2016

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.